Evaluation of hypoxia with copper-labeled diacetyl-bis(N-Methylthiosemicarbazone)

Seminars in Nuclear Medicine

Volumn 45, Issue 2, 2015, Pages 177-185

  Lapi, Suzanne E ^a,b   Lewis, Jason S ^c   Dehdashti, Farrokh ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Washington University in St Louis School of Medicine   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE IX; CYCLOOXYGENASE 2; DIACETYL BIS(N METHYLTHIOSEMICARBAZONE) CU 60; DIACETYL BIS(N METHYLTHIOSEMICARBAZONE) CU 62; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; COORDINATION COMPOUND; COPPER; THIOSEMICARBAZONE DERIVATIVE;

ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORONARY ARTERY DISEASE; CORPUS STRIATUM; DISEASE ACTIVITY; GLUCOSE METABOLISM; HEAD AND NECK CANCER; HEART MUSCLE ISCHEMIA; HYPOXIA; INTENSITY MODULATED RADIATION THERAPY; NEUROLOGIC DISEASE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RECTUM CANCER; ANIMAL; CELL HYPOXIA; CHEMISTRY; HUMAN; ISOTOPE LABELING; MOLECULAR IMAGING; PROCEDURES;

ANIMALS; CELL HYPOXIA; COORDINATION COMPLEXES; COPPER RADIOISOTOPES; HUMANS; ISOTOPE LABELING; MOLECULAR IMAGING; THIOSEMICARBAZONES;

EID: 84924050395     PISSN: 00012998     EISSN: 15584623     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2014.10.003     Document Type: Review

References (60)

1. D.M. Brizel, S.P. Scully, and J.M. Harrelson Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma Cancer Res 56 1996 941 943
2. D.M. Brizel, G.S. Sibley, and L.R. Prosnitz Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck Int J Radiat Oncol Biol Phys 38 1997 285 289
3. A.W. Fyles, M. Milosevic, and R. Wong Oxygenation predicts radiation response and survival in patients with cervix cancer Radiother Oncol 48 1998 149 156
4. P. Kolstad Intercapillary distance, oxygen tension and local recurrence in cervix cancer Scand J Clin Lab Invest Suppl 106 1968 145 157
5. R.A. Gatenby, H.B. Kessler, and J.S. Rosenblum Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy Int J Radiat Oncol Biol Phys 14 1988 831 838
6. J.P. Holland, J.S. Lewis, and F. Dehdashti Assessing tumor hypoxia by positron emission tomography with Cu-ATSM Q J Nucl Med Mol Imaging 53 2009 193 200
7. A.L. Vavere, and J.S. Lewis Cu-ATSM: A radiopharmaceutical for the PET imaging of hypoxia Dalton Trans 2007 4893 4902
8. S.E. Lapi, T.F. Voller, and M.J. Welch Positron emission tomography imaging of hypoxia PET Clin 4 2009 39 47
9. B.M. Zeglis, J.L. Houghton, and M.J. Evans Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals Inorg Chem 53 2014 1880 1899
10. L.H. Damelin, R. Jivan, and R.B. Veale Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones) BMC Cancer 14 2014 314
11. 64Cu-ATSM: Enhanced DNA damage and cytotoxicity in hypoxic cells Eur J Nucl Med Mol Imaging 37 2010 330 338
12. J.L. Dearling, and A.B. Packard Some thoughts on the mechanism of cellular trapping of Cu(II)-ATSM Nucl Med Biol 37 2010 237 243
13. R. Hueting, V. Kersemans, and B. Cornelissen A comparison of the behavior of (64)Cu-acetate and (64)Cu-ATSM in vitro and in vivo J Nucl Med 55 2014 128 134
14. A.L. Vavere, and J.S. Lewis Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines Nucl Med Biol 35 2008 273 279
15. 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer J Nucl Med 54 2013 1106 1112
16. S. Carlin, H. Zhang, and M. Reese A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers J Nucl Med 55 2014 515 521
17. M.M. Clausen, A.E. Hansen, and P.M. Af Rosenschold Dose escalation to high-risk sub-volumes based on non-invasive imaging of hypoxia and glycolytic activity in canine solid tumors: A feasibility study Radiat Oncol 8 2013 262
18. 61Cu-ATSM PET in canine sinonasal tumors J Nucl Med 54 2013 1931 1937
19. A.E. Hansen, A.T. Kristensen, and J.T. Jorgensen (64)Cu-ATSM and (18)FDG PET uptake and (64)Cu-ATSM autoradiography in spontaneous canine tumors: Comparison with pimonidazole hypoxia immunohistochemistry Radiat Oncol 7 2012 89
20. 18FDG PET/CT and dynamic contrast enhanced perfusion CT Radiother Oncol 102 2012 424 428
21. Y. Fujibayashi, C.S. Cutler, and C.J. Anderson Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: Ex vivo imaging of hypoxia in rats Nucl Med Biol 26 1999 117 121
22. J.S. Lewis, P. Herrero, and T.L. Sharp Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone) J Nucl Med 43 2002 1557 1569
23. N. Takahashi, Y. Fujibayashi, and Y. Yonekura Copper-62 ATSM as a hypoxic tissue tracer in myocardial ischemia Ann Nucl Med 15 2001 293 296
24. 64Cu-ATSM in cardiac myocytes using a novel incubation chamber for screening hypoxia-dependent radiotracers Nucl Med Commun 34 2013 1015 1022
25. 64Cu-ATSM J Nucl Med 55 2014 488 494
26. D.J. Williamson, S. Ejaz, and S. Sitnikov A comparison of four PET tracers for brain hypoxia mapping in a rodent model of stroke Nucl Med Biol 40 2013 338 344
27. Q.T. Le, E. Chen, and A. Salim An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers Clin Cancer Res 12 2006 1507 1514
28. 62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer Ann Nucl Med 14 2000 323 328
29. 62Cu-PTSM is a useful imaging tool for hypoxia and perfusion in pulmonary lesions AJR Am J Roentgenol 201 2013 W698 W706
30. 60Cu-ATSM Eur J Nucl Med Mol Imaging 30 2003 844 850
31. 18F-FDG in lung cancer J Nucl Med 50 2009 1948 1953
32. 2 predicts survival in advanced cancer of the uterine cervix Radiother Oncol 26 1993 45 50
33. 60Cu-ATSM: Relationship to therapeutic response-a preliminary report Int J Radiat Oncol Biol Phys 55 2003 1233 1238
34. 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone) J Nucl Med 49 2008 201 205
35. P.W. Grigsby, R.S. Malyapa, and R. Higashikubo Comparison of molecular markers of hypoxia and imaging with (60)Cu-ATSM in cancer of the uterine cervix Mol Imaging Biol 9 2007 278 283
36. J. Mattern, F. Kallinowski, and C. Herfarth Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer Int J Cancer 67 1996 20 23
37. E. Korkeila, K. Talvinen, and P.M. Jaakkola Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer Br J Cancer 100 2009 874 880
38. 60Cu-ATSM as a predictor of response and survival in patients undergoing neoadjuvant chemoradiotherapy for rectal carcinoma: A pilot study Dis Colon Rectum 51 2008 1641 1648
39. A. Rousseau, and B. Cécile Head and neck: Squamous cell carcinoma: An overview Atlas Genet Cytogenet Oncol Haematol 16 2012 143 153
40. J.P. Machiels, M. Lambrecht, and F.X. Hanin Advances in the management of squamous cell carcinoma of the head and neck F1000Prime Rep 6 2014 44
41. M.F. Adam, E.C. Gabalski, and D.A. Bloch Tissue oxygen distribution in head and neck cancer patients Head Neck 21 1999 146 153
42. M. Nordsmark, S.M. Bentzen, and V. Rudat Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study Radiother Oncol 77 2005 18 24
43. K.S. Chao, W.R. Bosch, and S. Mutic A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy Int J Radiat Oncol Biol Phys 49 2001 1171 1182
44. 62Cu-ATSM PET/CT as a predictor of response in head and neck cancer: A pilot study Ann Nucl Med 25 2011 339 345
45. A. Kositwattanarerk, M. Oh, and T. Kudo Different distribution of (62)Cu ATSM and (18)F-FDG in head and neck cancers Clin Nucl Med 37 2012 252 257
46. D.N. Louis, H. Ohgaki, and O.D. Wiestler The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 114 2007 97 109
47. R.L. Jensen Brain tumor hypoxia: Tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target J Neurooncol 92 2009 317 335
48. T. Kayama, T. Yoshimoto, and S. Fujimoto Intratumoral oxygen pressure in malignant brain tumor J Neurosurg 74 1991 55 59
49. 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1alpha expression in patients with glioma Am J Neuroradiol 34 2013 92 99
50. A. Hino-Shishikura, U. Tateishi, and H. Shibata Tumor hypoxia and microscopic diffusion capacity in brain tumors: A comparison of (62)Cu-Diacetyl-Bis (N4-Methylthiosemicarbazone) PET/CT and diffusion-weighted MR imaging Eur J Nucl Med Mol Imaging 41 2014 1419 1427
51. S. Warach, D. Chien, and W. Li Fast magnetic resonance diffusion-weighted imaging of acute human stroke Neurology 42 1992 1717 1723
52. R. Murakami, T. Hirai, and T. Sugahara Grading astrocytic tumors by using apparent diffusion coefficient parameters: Superiority of a one- versus two-parameter pilot method Radiology 251 2009 838 845
53. W.A. Tome, and J.F. Fowler Selective boosting of tumor subvolumes Int J Radiat Oncol Biol Phys 48 2000 593 599
54. Y. Yang, and L. Xing Towards biologically conformal radiation therapy (BCRT): Selective IMRT dose escalation under the guidance of spatial biology distribution Med Phys 32 2005 1473 1484
55. M.A. Deveau, S.R. Bowen, and D.C. Westerly Feasibility and sensitivity study of helical tomotherapy for dose painting plans Acta Oncol 49 2010 991 996
56. S.S. Korreman, S. Ulrich, and S. Bowen Feasibility of dose painting using volumetric modulated arc optimization and delivery Acta Oncol 49 2010 964 971
57. 60Cu-ATSM in cancer of the uterine cervix J Nucl Med 49 2008 1177 1182
58. M. Ikawa, H. Okazawa, and K. Arakawa PET imaging of redox and energy states in stroke-like episodes of MELAS Mitochondrion 9 2009 144 148
59. 62Cu-ATSM PET for evaluation of brain ischaemia and misery perfusion in patients with cerebrovascular disease Eur J Nucl Med Mol Imaging 38 2011 1075 1082
60. 62Cu]ATSM PET Nucl Med Biol 38 2011 945 951